Login / Signup

Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study.

Shyamashis DasRudra Prosad GoswamiDebanjali SinhaAnirban GhosalAshis DattaSanjukta Sarkar
Published in: International journal of rheumatic diseases (2022)
This study showed efficacy and safety of leflunomide as a steroid-sparing agent in Indian GCA patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • giant cell
  • patient reported outcomes
  • combination therapy